Cutaneous adverse drug reactions notified by pharmacovigilance in a tertiary care hospital in north India

References

• Shinkai K, Stern RS, Wintroub BU. Cutaneous drug reactions. In: Longo DL, Fauci AS, Kasper DL, et al., eds. Harrison's principles of internal medicine. 18th ed. New York: McGraw-Hill Companies, United States of America; 2012:432--440
   Google Scholar
• Arulmani R, Rajendran AD, Suresh B. Adverse drug reaction monitoring in a secondary care hospital in South India. Br J Clin Pharmacol 2007;65:210–216
   PubMed Web of Science ®Google Scholar
• Naldi L, Conforti A, Venegoni M, et al. Cutaneous reactions to drug: an analysis of spontaneous reports in four Italian regions. Br J Clin Pharmacol 1999;48:839–846
   PubMed Web of Science ®Google Scholar
• Pudukadan D, Thappa DM. Adverse cutaneous drug reactions: clinical pattern and causative agents in a tertiary care center in South India. Indian J Dermatol Venereol Leprol 2004;70:20–24
   PubMedGoogle Scholar
• Fiszenson-Albala F, Auzerie V, Mahe E, et al. A 6-month prospective survey of cutaneous drug reactions in a hospital setting. Br J Dermatol 2003;149:1018–1022
   PubMed Web of Science ®Google Scholar
• Borch JE, Andersen KE, Bindslev-Jensen C. The prevalence of acute cutaneous drug reactions in a Scandinavian university hospital. Acta Derm Venereol 2006;86:518–522
   PubMed Web of Science ®Google Scholar
• Sharma VK, Sethuraman G, Kumar B. Cutaneous adverse drug reactions: clinical pattern and causative agents – a 6 year series from Chandigarh, India. J Postgrad Med 2001;47:95–99
   PubMedGoogle Scholar
• Sushma M, Noel MV, Ritika MC, et al. Cutaneous adverse drug reactions: a 9-year study from a South Indian Hospital. Pharmacoepidemiol Drug Saf 2005;14:567–570
   PubMed Web of Science ®Google Scholar
• Nayak S, Acharjya B. Adverse cutaneous drug reaction. Indian J Dermatol 2008;53:2–8
   PubMedGoogle Scholar
• Schumock GT, Thornton JP. Focusing on the preventability of adverse drug reactions. Hosp Pharm 1992;27:538
   PubMedGoogle Scholar
• Inbaraj SD, Muniappan M, Muthiah NS, et al. Pharmacovigilance of the cutaneous drug reactions in outpatients of dermatology department at a tertiary care hospital. J Clin Diagn Res 2012;6:1688–1691
   Google Scholar
• Patel RM, Marfatia YS. Clinical study of cutaneous drug eruptions in 200 patients. Indian J Dermatol Venereol Leprol 2008;74:430
   PubMed Web of Science ®Google Scholar
• Saha A, Das NK, Hazra A, et al. Cutaneous adverse drug reaction profile in a tertiary care out patient setting in Eastern India. Indian J Pharmacol 2012;44:792–797
   PubMed Web of Science ®Google Scholar
• Wang F, Li Y, Mo Y, et al. Cutaneous adverse drug reactions: an 8-year retrospective study on hospitalized patients in Southern China. Indian J Dermatol Venereol Leprol 2012;78:488–490
   PubMed Web of Science ®Google Scholar
• Choon SE, Lai NM. An epidemiological and clinical analysis of cutaneous adverse drug reactions seen in a tertiary hospital in Johor, Malaysia. Indian J Dermatol Venereol Leprol 2012;78:734–739
   PubMed Web of Science ®Google Scholar
• Turk BG, Gunaydin A, Ertam I, Ozturk G. Adverse cutaneous drug reactions among hospitalized patients: five year surveillance. Cutan Ocul Toxicol 2013;32:41–45
   PubMed Web of Science ®Google Scholar
• Hiware S, Shrivastava M, Mishra D, et al. Evaluation of cutaneous drug reactions in patients visiting out patient departments of Indira Gandhi Government Medical College and Hospital, Nagpur. Indian J Dermatol 2013;58:18–21
   PubMedGoogle Scholar
• Bygum A, Gregersen JW, Buus SK. Acetaminophen-induced toxic epidermal necrolysis in a child. Pediatr Dermatol 2004;21:236–238
   PubMed Web of Science ®Google Scholar
• Halevi A, Ben-Amitai D, Garty BZ. Toxic epidermal necrolysis associated with acetaminophen ingestion. Ann Pharmacother 2000;34:32–34
   PubMed Web of Science ®Google Scholar
• Rajagopalan S, Kaur S, Dogra S, et al. Toxic epidermal necrolysis induced by rarely implicated drugs. Indian J Pharmacol 2012;44:272–273
   PubMed Web of Science ®Google Scholar
• Roujeau JC, Kelly JP, Naldi L, et al. Medication use and the risk of Stevens--Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 1995;333:1600–1607
   PubMed Web of Science ®Google Scholar
• Devi K, George S, Criton S, et al. Carbamazepine – the commonest cause of toxic epidermal necrolysis and Stevens--Johnson syndrome: a study of 7 years. Indian J Dermatol Venereol Leprol 2005;71:325–328
   PubMedGoogle Scholar
• Nakatani K, Kurose T, Hyo T, et al. Drug-induced generalized skin eruption in a diabetes mellitus patient receiving a dipeptidyl peptidase-4 inhibitor plus metformin. Diabetes Ther 2012;3:14
   Google Scholar
• Desai S, Brinker A, Swann J, Solomon I. Sitagliptin-associated drug allergy: review of spontaneous adverse event reports. Arch Intern Med 2010;170:1169–1170
   PubMed Web of Science ®Google Scholar
• Roujeau JC, Guillaume JC, Fabre JP, et al. Toxic epidermal necrolysis (Lyell syndrome). Incidence and drug etiology in France. Arch Dermatol 1990;126:37–42
   PubMed Web of Science ®Google Scholar
• Alanko K, Stubb S, Kauppinen K. Cutaneous drug reactions: clinical types and causative agents. A five-year survey of in-patients. Acta Derm Venereol 1989;69:223–226
   PubMed Web of Science ®Google Scholar
• Kauppinen K, Stubb S. Drug eruptions: causative agents and clinical types. A series of in-patients during a 10-year period. Acta Derm Venereol 1984;64:320–324
   PubMed Web of Science ®Google Scholar
• Wong KC, Kennedy PJ, Lee S. Clinical manifestations and outcomes in 17 cases of Stevens--Johnson syndrome and toxic epidermal necrolysis. Australas J Dermatol 1999;40:131–134
   PubMedGoogle Scholar
• Naveen KN, Pai W, Rai V. Retrospective analysis of Steven Johnson syndrome and toxic epidermal necrolysis over a period of 5 years from northern Karnataka, India. Indian J Pharmacol 2013;45:80–82
   PubMed Web of Science ®Google Scholar
• Naveen K, Arunkumar J, Hanumanthayya K, Pai V. Stevens--Johnson syndrome induced by sodium valproate monotherapy. Int J Crit Illn Inj Sci 2012;2:44–45
   Google Scholar
• Yamane Y, Aihara M, Ikezawa Z. Analysis of Stevens--Johnson syndrome and toxic epidermal necrolysis in Japan from 2000 to 2006. Allergol Int 2007;56:419–425
   PubMedGoogle Scholar
• Teich JM, Merchia PR, Schmiz JL, et al. Effects of computerized physician order entry on prescribing practices. Arch Intern Med 2000;160:2741–2747
   PubMed Web of Science ®Google Scholar